How IPO readiness diligence differs from M&A FDD - prospectus liability, longer audit history, forecast credibility and governance - and why the bar rises for a TS analyst.
A private M&A buyer who finds a problem in diligence can price it, wrap a warranty around it, or walk away. A public-market investor who finds the same problem eighteen months after the listing can join a class action. That single difference - one sophisticated counterparty who can protect itself, versus thousands of retail and institutional investors with legal recourse and a long memory - is why IPO readiness diligence is not simply "FDD but bigger". It is a different exercise, with a different audience, a different standard of proof, and a much longer shadow. If you already understand ordinary financial due diligence, you own most of the toolkit. What changes is who is relying on your numbers, and for how long - and that change reaches into every judgement you make.
In a bilateral deal, findings feed a negotiation. If a target has messy revenue recognition, the buyer chips the price, tightens the SPA, takes an indemnity, and moves on. The information asymmetry is resolved privately, between two parties who can each afford advisers and each accept a share of the risk with their eyes open.
An IPO inverts that logic. The company makes representations to the general investing public through a prospectus - a document that carries real legal liability if it contains a material misstatement or a material omission. Directors sign it. Underwriters attach their names and their reputations. The governing question shifts from "does this change what one buyer should pay today" to "could this become a regulatory or litigation problem once thousands of investors are relying on it, indefinitely."
The M&A question is "what is it worth to one buyer today?" The IPO question is "will these numbers survive public scrutiny every quarter, for years?" The second bar is materially higher - and everything downstream flows from it.
That reframing touches every workstream. A judgement a private buyer would accept with a raised eyebrow - an aggressive capitalisation policy, a soft revenue cut-off, a convenient one-off - becomes something that must be defensible under a regulator's gaze, not merely negotiable across a table. You are no longer helping someone decide a price. You are helping build a set of numbers that will be tested, publicly and repeatedly, by people who were not in the room and are not feeling generous.
IPO candidates typically need audited financial statements covering a longer historical track record than a private M&A deal requires - commonly three years of audited accounts, prepared to a standard robust enough to withstand review by a securities regulator, an exchange, or both. A founder-led business that has run adequate-but-informal reporting for years frequently needs a genuine uplift in control and reporting discipline before a listing is realistic at all. Spotting that gap early - and sizing the work and time to close it - is itself part of the value the diligence adds.
This is where standard TS skills transfer directly, but the tolerance shrinks. The instincts you use for revenue quality and EBITDA adjustments still apply - but a normalisation you would happily book as a one-off in an M&A quality of earnings analysis may need to be genuinely audit-supportable, not just commercially reasonable, before it can sit in a prospectus. The gap between "a buyer would accept this" and "an auditor and a regulator will accept this" is exactly where IPO diligence earns its fee.
Consider a worked example. A software business reports management-accounts EBITDA of £20.0m. In an M&A process you would present a QoE bridge to a normalised figure. For an IPO, each line must also clear an audit-and-disclosure threshold, and some adjustments a private buyer would wave through simply do not survive.
| Item | M&A QoE treatment | IPO-standard treatment | EBITDA impact |
|---|---|---|---|
| Reported EBITDA | £20.0m | £20.0m | - |
| Owner's above-market salary add-back | Accepted | Accepted (disclosed related party) | +£0.8m |
| One-off rebrand costs | Add-back | Add-back (audit-supported) | +£0.6m |
| "Non-recurring" consulting (recurs 3 yrs) | Often accepted | Rejected - pattern is recurring | −£0.5m |
| Aggressive dev-cost capitalisation | Diligenced | Partly reversed to opex | −£0.9m |
| Defensible normalised EBITDA | £21.4m | £20.0m | flat |
The M&A read flatters the business by £1.4m. The IPO read, disciplined by what an auditor and regulator will accept, lands back at the reported figure. Same company, same data, two different numbers - because the audience changed. That single table is the whole lesson: the adjustment is not measured against a buyer's willingness to nod, but against a standard of proof that outlasts the transaction.
Public companies face far stricter rules and higher liability around forward-looking guidance than a private company negotiating a single deal. So IPO readiness work scrutinises the forecasting process - and the target's historical forecast accuracy - far more heavily than a routine FDD engagement.
A business that habitually misses its own budget by wide margins has a credibility problem to solve before it can responsibly guide public-market expectations. The diligence question is not only "is the forecast achievable" but "does this management team have a demonstrable track record of hitting the numbers it sets itself." A quick way to frame it is a budget-versus-actual history:
| Year | Budgeted revenue | Actual revenue | Variance |
|---|---|---|---|
| FY-3 | £48.0m | £41.5m | −13.5% |
| FY-2 | £55.0m | £49.2m | −10.5% |
| FY-1 | £60.0m | £58.9m | −1.8% |
The trend is improving, which is a genuinely encouraging story - but the FY-3 and FY-2 misses are precisely the kind of history that must be understood, explained, and ideally shown to be behind the business before its forward guidance can be relied upon in a prospectus. This links closely to revenue quality and to how much of the forecast rests on recurring revenue versus one-off wins that may not repeat. A forecast anchored in contracted, recurring revenue is far more defensible to the market than one that depends on landing a handful of large, discretionary deals each year.
Informal arrangements that pass with little comment in a private deal face a colder reception at the door of the public market. Owner loans, family-member consulting contracts, property leased from a director, intercompany balances with no arm's-length basis - these must typically be formally disclosed, restructured, or unwound before listing.
The mechanics overlap with what you already check in a net debt build, where related-party balances and shareholder loans routinely get reclassified. The crucial difference is that an IPO cannot simply price the item into a bridge and settle it at completion the way locked-box or completion-accounts mechanics resolve an M&A deal. The arrangement itself usually has to change. You cannot list a company with a director quietly renting it a warehouse at twice the market rate and expect a regulator to shrug. Governance follows the same logic: informal founder oversight is replaced by institutional-grade board composition, independent non-executives, audit committees, and documented controls that can be described credibly to prospective investors.
None of this makes your existing skills redundant - quite the opposite. Normalising earnings, building a defensible net debt position, sizing working capital and its normal seasonality, distinguishing maintenance from growth spend: all of it transfers directly. What changes is the standard of proof and the permanence of the audience.
Two technical areas deserve a specific mention because the public-market lens sharpens them. The first is lease accounting: under IFRS 16, operating leases sit on the balance sheet as right-of-use assets and lease liabilities, and how a listing prospectus presents and reconciles those balances - and their effect on reported EBITDA versus a pre-IFRS 16 view - has to be crystal clear and consistent, because analysts will rebuild the bridge themselves and query any gap. The second is the normalised working-capital position: an M&A deal resolves it through a negotiated target, settled once at completion, whereas a public company has to demonstrate a stable, well-understood working-capital profile quarter after quarter, with seasonality explained rather than smoothed away. In both cases the underlying analysis is familiar TS work; what changes is that the answer must hold up to repeated, adversarial public scrutiny rather than a single private settlement.
An M&A number defends itself once, to one counterparty, on one day. An IPO number defends itself continuously, to the market and its regulator, for as long as the company remains listed. The same FDD report structure discipline - clear bridges, documented adjustments, every number sourced back to primary evidence - becomes even more valuable, because the working papers may eventually be scrutinised by people who were not present and have no reason to give the benefit of the doubt. The habits that make you merely tidy in an M&A process make you genuinely defensible in a capital-markets one.
IPO readiness is a genuine, if smaller, adjacent market to standard M&A-driven TS work, and it increasingly rewards analysts who understand the distinction. Two practical reasons matter for your career. First, it broadens where you can work - capital-markets and IPO-advisory practices sit alongside the deal-focused teams covered in the salary guide, and firms value people who can move between the two. Second, private-equity exits sometimes take the IPO route, so diligence you perform on an acquisition today may feed directly into IPO preparation for the same asset a few years later. Recognising when a business is being quietly groomed for a public exit changes how you read a data room - you start looking not just at what a buyer would pay, but at what the market would tolerate.
There is a reputational dimension too. Work that ends up underpinning a prospectus is, by its nature, high-visibility and high-stakes, and analysts who can be trusted with it tend to be given more of it. Learning to hold your own numbers to the audit-and-disclosure standard, rather than the merely-negotiable one, is a habit that travels well back into ordinary M&A work - a defensible bridge is a defensible bridge whoever is reading it.
Interviewers use IPO readiness to test whether you understand why diligence exists, not just how to run it. Expect: "How does due diligence for an IPO differ from a standard M&A FDD?"
"The core technical work is similar - I'm still normalising EBITDA, building net debt, and assessing revenue quality. What changes is the audience and the standard of proof. In M&A, I'm informing one sophisticated buyer who can price any issue into the deal or take a warranty. In an IPO, the company is making representations to the public through a prospectus, which carries legal liability for a material misstatement. So the bar rises in three concrete ways. First, adjustments have to be genuinely audit-supportable, not just commercially reasonable - a one-off I'd accept in a QoE might get reversed for an IPO. Second, forecasting gets far more scrutiny, because public guidance carries liability, so I'd look hard at historical budget-versus-actual accuracy and how much of the forecast is contracted, recurring revenue. Third, related-party arrangements that a buyer would just settle in the completion mechanism usually have to be formally unwound before listing, alongside a real uplift in governance and controls. Same toolkit, higher and more permanent bar."
That answer works because it leads with the transferable skill, then names the specific ways the standard rises - which is exactly the distinction the question is probing.
An IPO is the moment a company stops being answerable to one buyer and starts being answerable to everyone, indefinitely. The diligence that supports it is your familiar toolkit held to an unfamiliar standard - every adjustment audit-ready, every forecast credibly earned, every related-party skeleton out of the cupboard before the bell rings. Learn to see that higher bar, and you become useful not just on the deal in front of you, but on the exit that same asset may take years down the line.
The Transaction Services Interview Programme (€119.99, one-time) includes a dedicated module on IPO readiness diligence - how the prospectus liability standard reshapes normalisation, forecast scrutiny, and related-party checks, with worked examples and interview answers. Enrol today.
Hundreds of candidates prepared their interviews with this programme. Those who landed the role have one thing in common: they worked the cases before walking into the room.
